Muenter MD - Search Results

1

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.

Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y. Tong J, et al. Among authors: muenter md. Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10. Brain. 2010. PMID: 19903734

2

Hereditary form of parkinsonism--dementia.

Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ, Okazaki H, Howard FM Jr, Snow BJ, Calne DB. Muenter MD, et al. Ann Neurol. 1998 Jun;43(6):768-81. doi: 10.1002/ana.410430612. Ann Neurol. 1998. PMID: 9629847

3

An examination of male-female differences in progression and mortality of Parkinson's disease.

Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD. Diamond SG, et al. Among authors: muenter md. Neurology. 1990 May;40(5):763-6. doi: 10.1212/wnl.40.5.763. Neurology. 1990. PMID: 2330103

4

Effect of age at onset on progression and mortality in Parkinson's disease.

Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD. Diamond SG, et al. Among authors: muenter md. Neurology. 1989 Sep;39(9):1187-90. doi: 10.1212/wnl.39.9.1187. Neurology. 1989. PMID: 2771070

5

Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.

Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, O'Brien PC. Uitti RJ, et al. Among authors: muenter md. Neurology. 1993 Oct;43(10):1918-26. doi: 10.1212/wnl.43.10.1918. Neurology. 1993. PMID: 8413948

6

Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.

Gwinn-Hardy K, Mehta ND, Farrer M, Maraganore D, Muenter M, Yen SH, Hardy J, Dickson DW. Gwinn-Hardy K, et al. Acta Neuropathol. 2000 Jun;99(6):663-72. doi: 10.1007/s004010051177. Acta Neuropathol. 2000. PMID: 10867800

7

Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.

Hutton JT, Koller WC, Ahlskog JE, Pahwa R, Hurtig HI, Stern MB, Hiner BC, Lieberman A, Pfeiffer RF, Rodnitzky RL, Waters CH, Muenter MD, Adler CH, Morris JL. Hutton JT, et al. Among authors: muenter md. Neurology. 1996 Apr;46(4):1062-5. doi: 10.1212/wnl.46.4.1062. Neurology. 1996. PMID: 8780092 Clinical Trial.

8

Skin lesion with a fatal neurologic outcome (Degos' disease).

Subbiah P, Wijdicks E, Muenter M, Carter J, Connolly S. Subbiah P, et al. Neurology. 1996 Mar;46(3):636-40. doi: 10.1212/wnl.46.3.636. Neurology. 1996. PMID: 8618659

9

Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline.

Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF, Wheeler K. Ahlskog JE, et al. Among authors: muenter md. Arch Neurol. 1994 Dec;51(12):1236-41. doi: 10.1001/archneur.1994.00540240080020. Arch Neurol. 1994. PMID: 7986180 Clinical Trial.

10

PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agent.

Muenter MD, Ahlskog JE, Bell G, McManis P. Muenter MD, et al. Neurology. 1988 Oct;38(10):1541-5. doi: 10.1212/wnl.38.10.1541. Neurology. 1988. PMID: 2901697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters